Showing results (101-110 of 1,128) with videos related to
Sort By:
Pageof 113
Journal of Hepatocellular Carcinoma|March 18, 2022
Postoperative Adjuvant Transarterial Chemoembolization Plus Tyrosine Kinase Inhibitor for Hepatocellular Carcinoma: a Multicentre Retrospective StudyKongying Lin, Fuqun Wei, Qizhen Huang, et al.Journal of Hepatocellular Carcinoma|March 18, 2022
Regorafenib Combined with PD-1 Blockade Immunotherapy versus Regorafenib as Second-Line Treatment for Advanced Hepatocellular Carcinoma: A Multicenter Retrospective StudyJingjun Huang, Yongjian Guo, Wensou Huang, et al.Journal of Hepatocellular Carcinoma|April 5, 2022
Autoantibody Against Ferritin Light Chain is a Serum Biomarker for the Detection of Liver Cirrhosis but Not Liver CancerPengfei Ren, Keyan Wang, Jie Ma, et al.Journal of Hepatocellular Carcinoma|July 30, 2019
Prospective Phase II trial of drug-eluting bead chemoembolization for liver transplant candidates with hepatocellular carcinoma and marginal hepatic reserveNicholas Fidelman, Curt Johanson, Maureen P Kohi, et al.Journal of Hepatocellular Carcinoma|August 21, 2018
Hepatitis C virus-associated hepatocellular carcinoma as a second primary malignancy: exposing an overlooked presentation of liver cancerDima Dandachi, Manal Hassan, Ahmed Kaseb, et al.Journal of Hepatocellular Carcinoma|August 11, 2017
Transarterial chemoembolization for the treatment of hepatocellular carcinoma: a reviewRodolfo Sacco, Gherardo Tapete, Natalia Simonetti, et al.Journal of Hepatocellular Carcinoma|November 30, 2017
Optimal therapy for patients with hepatocellular carcinoma and resistance or intolerance to sorafenib: challenges and solutionsEmily M Ray, Hanna K SanoffJournal of Hepatocellular Carcinoma|February 7, 2018
Pretreatment neutrophil-lymphocyte ratio: useful prognostic biomarker in hepatocellular carcinomaMarc Najjar, Surbhi Agrawal, Jean C Emond, et al.Journal of Hepatocellular Carcinoma|April 6, 2026
Erratum: Early PIVKA-II Response Predicts Treatment Efficacy of Immune Checkpoint Inhibitors in Patients with Advanced Hepatocellular Carcinoma [Corrigendum]Journal of Hepatocellular Carcinoma|April 2, 2026
MRI Radiomics for Distinguishing HBV-Related Early Hepatocellular Carcinoma from Precancerous NodulesJiachen Liu, Xiurong Ding, Yanyan Zhang, et al.Pageof 113